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ABSTRACT: A correct estimate of ligand binding modes and a ratio of their
occupancies is crucial for calculations of binding free energies. The newly
developed method BLUES combines molecular dynamics with nonequilibrium
candidate Monte Carlo. Nonequilibrium candidate Monte Carlo generates a
plethora of possible binding modes and molecular dynamics enables the system to
relax. We used BLUES to investigate binding modes of caffeine in the active site
of its metabolizing enzyme Cytochrome P450 1A2 with the aim of elucidating
metabolite-formation profiles at different concentrations. Because the activation
energies of all sites of metabolism do not show a clear preference for one
metabolite over the others, the orientations in the active site must play a key role.
In simulations with caffeine located in a spacious pocket above the I-helix, it
points N3 and N1 to the heme iron, whereas in simulations where caffeine is in
close proximity to the heme N7 and C8 are preferably oriented toward the heme
iron. We propose a mechanism where at low caffeine concentrations caffeine binds to the upper part of the active site, leading to
formation of the main metabolite paraxanthine. On the other hand, at high concentrations two molecules are located in the
active site, forcing one molecule into close proximity to the heme and yielding metabolites theophylline and trimethyluretic
acid. Our results offer an explanation of previously published experimental results.
■ INTRODUCTION
Human cytochromes P450 (CYP) are oxidoreductases with a
heme cofactor that are responsible for the Phase I metabolism
of 75% of drugs in the human body.1−3 There are 57
mammalian isoforms known and their inhibition, induction, or
allosteric effects by various small molecules often lead to a
number of drug−drug interactions. Cytochromes P450
catalyze a wide variety of reactions, that are in general
improving the water solubility either of their endogenous
substrates or xenobiotics. These reactions take place at the
functional groups of the molecules, also known as sites of
metabolism (SOM). A general rule-of-thumb is that poses for
which the distance between a SOM of a molecule to the heme
iron is not more than 6 Å are considered to be active binding
modes.4,5 Here, we chose the 1A2 isoform, which metabolizes
caffeine in four positions. Caffeine is a methylxanthine
neurostimulant, acting as a competitive antagonist of adenosine
receptors, that most Europeans consume every day.6−8
Caffeine, like many other aromatic and heterocyclic amines,
is metabolized by CYP1A2.9 CYP1A2 has a relatively narrow
and planar binding site (375 Å3) suitable for accommodation
of such amines. The active site is formed by the I-helix situated
above a cysteine-bound heme with residues Phe226 and
Asp320 playing a crucial role in the kinetics of the chemical
reaction.10,11
The exact binding modes of caffeine are unknown, however
the main metabolites are known and NMR studies
investigating the binding modes and their ratios have been
reported.12 The main metabolites of caffeine are paraxanthine
(PX) accounting for about 80% of product formation,
theobromine (TB) with about 10%, theophylline (TP) with
about 5%, and 1,3,7-trimethyluretic acid (TMU) with only 1%,
all of which are biologically active and further metabolized by
cytochrome P450s,13−16 shown in Figure 1.
Regal and Nelson12 observed a shift in the metabolite ratio
with increasing caffeine concentration, making theophylline the
main metabolite at higher caffeine concentrations. CYP1A2 in
its resting state is in the high spin state (HS) which is typically
associated with a penta-coordinated heme iron in its ferric
form.17 For other CYPs, the resting state involves coordination
of a water molecule as sixth ligand to the heme iron, leading to
a (measurable) low spin state (LS). The lack of a sixth-
coordinating water molecule in the resting state of CYP1A2
might be caused by the narrow hydrophobic active site of
CYP1A2, which might to some degree hamper coordination of
a water molecule with the heme iron.
A potential substrate binds to the active site in the resting
state, potentially in a fixed orientation. For CYP1A2, it was
shown that in the presence of higher concentrations of
substrate there was an incomplete shift (∼28%) from the high
spin to the low spin state.18 Regal and Nelson12 showed that
average distances of caffeine SOMs to the heme iron are
approximately 2 Å shorter for CYP1A2 in a 100% low spin
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state than in a 100% high spin state. Nevertheless, the distances
of all three nitrogens N1, N3, and N7 to the iron atom differ
less than 0.2 Å in both spin states, see Table S1. Similar
distances of all SOMs to the heme iron do not indicate a clear
binding mode leading to the known main metabolites in
human.
After substrate binding, diffusion of molecular oxygen to the
heme iron leads to the formation of compound one (CPDI)
with one oxygen atom bound to the iron in its ferryl state.
CPDI is a highly reactive species responsible for product
formation.
The aim of our work is to elucidate the binding modes of
caffeine with the CYP1A2 isoform by using the package
BLUES, which can by NCMC lead to a better sampling of
ligand orientations.
Activation Energy. The activation energy of the oxidation
reaction at each SOM determines the reactivity. Previous
studies show that the rate-limiting step in aliphatic oxidation is
the creation of a radical intermediate, that is, hydrogen
abstraction. The rate-limiting step for aromatic oxidation is the
creation of the bond between the oxygen bound to the iron
and the aromatic carbon. Rydberg and co-workers19 proposed
a method predicting these activation energies for potential
SOMs based on the effect of their surrounding atoms. This
method consists of a number of rules that are derived from
high-level density functional theory (DFT) calculations. The
calculated activation energies from Rydberg et al.19 are shown
in Table 1. The aliphatic oxidation on N7−C14 and aromatic
oxidation on C8 yielded the lowest activation energies, both 52
kJ/mol. The aliphatic oxidations on N3−C12 and N1−C10,
were slightly higher, ranging from 57 to 62 kJ/mol.
Despite the lower activation energies of N7−C14 and C8,
the overall energies differ by less than 10 kJ/mol, which does
not imply a distinctly higher reactivity of one SOM over the
others. Apparently, the activation energies alone do not explain
the preferred formation of PX (metabolism at N3−C12) but
rather suggest a preference for TP or TMU. Caffeine’s
orientation with respect to the heme might have a stronger
impact on its metabolism than its intrinsic reactivity.
Ligand Sampling. Enzymes catalyze chemical reactions
typically through a stabilization of the transition state in the
active site. The active site might be located on the surface of
the protein but might be also buried in the protein interior. In
those cases, a ligand or a substrate is steered by nonbonded
interactions through the protein along its binding path, passing
by potential subpockets until it reaches a reactive binding
mode in the protein active site. Assessing the correct ligand
binding modes and the ratios of their occurrences is essential
for the estimate of ligand binding strength and, for enzyme−
substrate complexes, the proper orientation of the substrate.
Binding modes play an important role in drug design where
one aims to predict the binding characteristics of a large
number of potential drug molecules to the target of interest.
Probably the most frequently used and the fastest method for
selection of the most likely binders is molecular docking.
Molecular docking positions a ligand into multiple binding
modes and selects the one with the lowest score (hopefully
roughly corresponding to a binding enthalpy) which can be
calculated in various ways.20 Docking can reach high
computational speed by neglecting the protein motion and
solvation. These factors have, however, a negative impact on
the accuracy of the results, which makes docking a “guiding
filter” to refine ligand libraries and select potentially active
binders. Docking does not accurately predict free-energies and
occupancies of different binding modes because of the lack of
physically accurate sampling.21 There are several more
extensive methods, employing molecular dynamics (MD)
simulations, that address these topics, such as replica
exchange,22−24 umbrella sampling with potential of mean
force25−27 and others.28−30 These methods are, however, often
rather laborious and need a significant amount of preparation
for individual systems. Alchemical methods that focus on the
relative free energies between individual ligands are often
initiated from a single binding pose for multiple ligands. This
way they ignore possible orientational differences between
ligands which might lead to higher errors and inconsistencies
with simulations that start from a different binding pose.31,32
A recently developed method, binding modes of ligands
using enhanced sampling (BLUES),33 addresses these issues.
The uniqueness of the BLUES method lies in the combination
of MD with a nonequilibrium candidate Monte Carlo
(NCMC) approach. The NCMC approach is based on the
naıv̈e Monte Carlo method while yielding higher acceptance
probabilities with shorter correlation times.34 NCMC
introduces a nonequilibrium phase, which consists of a number
of instantaneous perturbation steps separated by short
relaxation periods. Afterward the entire series is accepted or
rejected. In the particular implementation of NCMC used in
BLUES, the perturbations scale down the interactions, that is,
the potential energy of the ligand with its surroundings is
gradually changed to zero, followed by a ligand rotation around
its center of mass (COM) into a new orientation without
Figure 1. Main metabolites of caffeine. Caffeine is in the middle and
the SOM are depicted in colorful spheres. The main metabolite PX is
shown in cyan.
Table 1. Activation Energies for SOM of Caffeine Taken
from Rydberg et al.19 at Given SOMsa
SOM E [kJ/mol]
Aliphatic Oxidations
N1−C10 (TB) 61.7
N3−C12 (PX) 57.3
N7−C14 (TP) 52.1
Aromatic Oxidation
C8 (TMU) 52.2
aAbbreviations of the formed products in brackets.
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changing the potential energy of the system. After the ligand
rotation, the interactions are gradually turned on again (Figure
2). Coulombic interactions are turned off before the van der
Waals interactions, and after rotation interactions are turned
on in reverse order to avoid numerical instabilities and to
ensure reversibility.35
The acceptance criterium for the entire NCMC procedure is
derived from the Metropolis-Hastings criterium.36 The accept-
ance probability of process X, A[X] is computed as
[ ] = { }−A X min 1, e w X( ) (1)
where w is the protocol work of the procedure, estimated as
∑= [ − ]
=
−w X u x u x( ) ( ) ( )
t
T
t t t t
1
1
(2)
where xt is a microstate at a given simulation step and ut is the
reduced potential energy. Because a Langevin integrator is
used, w in eq 1 is complemented with the appropriate shadow
work.37 After each accepted or rejected move, the momenta
are randomly reassigned based on the Maxwell−Boltzmann
distribution in order to keep detailed balance.38 The NCMC
stage is followed by a series of conventional MD steps, using a
Langevin integrator to relax the entire system. BLUES creates a
trajectory of MD and accepted moves, which can be
subsequently clustered and used for estimating populations
of binding modes.
■ METHODS
The crystal structure of CYP1A2 with the PDB code 2HI439 with a
resolution of 1.95 Å was used as an input structure for all MD
simulations. The crystallized ligand α-naphthoflavone was subse-
quently removed and caffeine was docked into the active site using the
AutoDock Vina tool and AutoDock Vina scoring function.40 The
active site was defined as a cube with an edge length of 13 Å, centered
at the heme iron. Figure S1 shows the docking setup for both
receptors. The flexibility of the receptor was not considered. The nine
best scored docking poses were saved for further simulations.
Hydrogens were added to the protein using tleap from
AmberTools1741,42 and the protein was parametrized using the
ff99SB force field.43 The parameters for heme in the ferric form,
compound I, and neighboring cysteine were adopted from Shahrokh
et al.44 In a classical force field, no differences between ferric high spin
or low spin states are described. Hydrogens were added to caffeine
using AutoDockTools445 and caffeine was parametrized using the
GAFF46 force field with AM1-BCC charges.47 The docked proteins
were solvated in a rectangular box with TIP3P water molecules48 with
13 Å as the minimal protein-wall distance and 6 Cl− counterions were
added. The system was minimized and equilibrated for 6.2 ns using
OpenMM 7.1.149 under constant pressure at 1 atm with 300 K. A
Monte Carlo barostat and Langevin integrator were used with a 4 fs
time step while setting the hydrogen mass to 3.024 Da and using 1
ps−1 collision rate. The bond distance between hydrogen and heavy
atoms was constrained while using the hydrogen mass repartitioning
scheme.50 The particle Mesh Ewald method51 was used to calculate
the long-range electrostatics.
To generate reasonable starting structures for the simulations with
the ferric heme, all poses from the last 6 ns of equilibration were
merged and analyzed by time-structure-independent component
analysis (tICA) using PyEMMA 2.5.2.52,53 tICA was performed on
the pairwise-distances of the caffeine atoms and the alpha carbons of
the binding site with a lagtime of 200 ps and the frames were clustered
by PCCA.54,55 Four of the five most stable clusters were used for
standard MD and BLUES simulations. Note that the sole purpose of
the tICA analysis and clustering was to obtain initial structures for the
production simulations; from such short simulations, no conclusions
with respect to the orientational preferences of the substrate can be
deduced. Although tICA is also used in the context of building
Markov State Models for analysis of long MD simulations, that was
not our focus here; instead, we simply sought to identify potential
stable or metastable binding modes for further analysis via additional
simulations. For the CPDI simulations we did not perform clustering
but directly used the rather diverse original docking poses for standard
MD and BLUES simulations.
The production runs of standard MD with ferric heme and CPDI
were performed by OpenMM in the NVT ensemble without use of a
barostat. We have found that running BLUES with a barostat can
impair acceptance rates and, for a buried binding site like this, ligand
placement is unlikely to affect the pressure of the system. For
consistency, the standard MD simulations were also performed
without a barostat. In all cases, equilibration brought the systems to
the correct pressure prior to these production runs. The production
simulations were performed for 1 μs per docked pose.
BLUES version 0.1.3 was used. The BLUES calculations were
performed using openmmtools 0.13.056 to annihilate caffeine
Coulombic and van der Waals interactions. The MD part was
performed as described above by OpenMM’s Langevin integrator and
the NCMC part by the BAOAB integrator for Langevin dynamics.57
The protein and water residues further than 5 Å from the ligand were
constrained during the NCMC phase (though these are fully flexible
during the conventional MD phase) to improve acceptance, as in
previous work.33 For every perturbation step performed, three
additional propagation (or relaxation) steps were applied between λ
= 0.2 and 0.8. BLUES runs consisted of 1000 iterations, each of which
consisted of 10 000 NCMC steps and 10 000 MD steps. Thus, the
total simulation time of one BLUES run is equivalent to 20 × 106
force evaluations. The general scheme of the BLUES workflow is
depicted in Figure S2.
■ RESULTS AND DISCUSSION
In order to investigate binding modes of caffeine we included
two heme states of the CYP1A2 catalytic cycle. The first of
them was heme in its ferric resting state to which the substrate
binds and the second was CPDI, which plays a key role in the
actual substrate metabolism.
Heme with Ferric Iron. After the removal of the α-
naphthoflavone molecule from the crystal structure, caffeine
was docked into the active site of CYP1A2. The docking
Figure 2. Scaling of nonbonded interactions of the ligand with respect
to λ over the course of NCMC steps. At λ = 1 the ligand is fully
interacting, whereas at λ = 0 the interactions of the ligand are turned
off completely. The relaxation MD part is not included in this figure.
Adapted from Gill et al.33
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process resulted in multiple docking poses where at least one
functional moiety of caffeine would fulfill the 6 Å rule. Nine
well-scoring poses were selected for further simulations. After
the minimization and equilibration of docked poses, the feature
coordinates were transformed using tICA and subsequently
assigned to clusters using PCCA. From five suggested clusters,
four were chosen, because the representative structures of
clusters 2 and 3 were, based on visual inspection, almost
identical. The remaining four clusters were used to start
standard MD and BLUES simulations and are shown in Figure
3.
We measured distances of the four sites of metabolism,
depicted as C10 (neighboring N1), C12 (neighboring N3),
C14 (neighboring N7), and C8, as well as the running average
of the distance of the center of mass of caffeine depicted as
COM, all to the heme iron of the ferric state.
For the sake of clarity we compare in Figure 4 these
distances during standard MD and BLUES simulations of
cluster 1 and 4, as the behavior of caffeine in simulations
starting from clusters 0 and 3 resemble the data in cluster 1
(Figure S3). For clusters 0, 1, and 3, in BLUES we observed
binding modes consistent with a clear preference for
metabolism at C8 and C14, because these SOMs were
pointing to the heme iron for more than 90% of simulation
frames, see Table S3 and Figure 5. This trend can be seen in
MD simulations as well; however, in clusters 1 and 3 caffeine
tends to leave the close vicinity of the heme and reaches
distances around 10 Å from the heme iron. Because in BLUES
the trajectory is divided by the NCMC phase, caffeine does not
have the chance for bigger translational moves and remains at a
constant distance around 7 Å from the heme. Table S2 shows
the percentages of frames, in which the distance between the
caffeine SOMs and the heme iron is less than 6 Å. In BLUES
simulations, we could not observe any transitions between
different binding poses, leading to an average acceptance rate
of ∼3% in all cluster simulations. Table S1 summarizes average
distances of the carbon atoms from the heme iron as ⟨r⟩ and as
⟨r−6⟩−1/6 which are more representative to the distances that
are derived from NMR experiments.
Unlike simulations of clusters 0, 1, and 3, simulations of
cluster 4 started from a position where the COM of caffeine
was 10 Å from the heme iron. In BLUES simulations of cluster
Figure 3. Starting poses for MD and BLUES simulations. The amino acids in sticks are he226 and Asp320, the purple sphere represents a sphere of
6 Å around the heme iron. Caffeine SOMs C10 is in orange, C12 is in cyan, C14 is in dark red, and C8 is in marine blue. The nitrogen atoms to
which C10, C12, and C14 are bound, as well as C8, are labeled as well as Phe226.
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4, we observe a higher number of transitions, repeatedly
placing all four SOMs of caffeine toward the heme, shown in
Figure 4. In MD simulations of cluster 4, caffeine first comes
closer to the heme to around 8 Å, then leaves the active site
Figure 4. Time series of the distance from the heme iron (ferric state) to indicated atoms in caffeine and its center of mass (COM). The right-
hand-side panels show the corresponding histograms.
Figure 5. Ratio of the closest SOMs to the heme iron in all simulations. The bars are ordered according to the average COM-Fe distance. We can
observe an orientational change in the position where the COM-Fe distance is larger than 9 Å. The exact values and error estimates are shown in
Table S7.
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and rotates. In both simulations, MD and BLUES, caffeine
reaches a metastable pose where C12, which is the methyl
group that when cleaved yields the main metabolite PX, is
oriented toward the heme iron in more than 50% of simulation
frames. It is important to note that in both simulations of
cluster 4, C12 does not reach the distance of 6 Å to the heme
iron, which is considered to be necessary for the SOM
metabolism to take place.
To obtain a better view of the different binding modes, we
measured distances from the center of mass of the aromatic
cluster (Phe226, Phe256, and Phe260) and the ligand, see
Figure S6. We note that when caffeine leaves the close vicinity
of the heme, which is the case for clusters 1, 3, and 4, it
approaches this aromatic cluster. Favorable aromatic inter-
actions can be the cause of caffeine movement during the MD
simulations.
Several factors may cause the differences between BLUES
and MD simulations. In BLUES simulations, caffeine does not
leave the close vicinity of the heme, because the simulation is
constantly interrupted by a series of NCMC steps where it can
adjust its orientation. The MD simulations on the other hand,
offer a long continuous run where the caffeine molecule has a
chance to diffuse away from the direct vicinity of the heme,
from which we learn that a single caffeine molecule prefers to
bind further away from the heme. The strength of BLUES,
however, lies in the effective sampling of all relevant binding
modes, where it surpasses standard MD simulations (e.g.,
cluster 4 in Figure 4).
Measured distances of MD simulations of four additional
docked poses that were not used in BLUES are in the
Supporting Information (Figure S4), most of them with C14
and C8 oriented toward the heme.
Compound I. Starting poses for simulations with
Compound I (CPDI) were obtained from docking using the
same procedure as described for the ferric state of the enzyme.
These were, however, not clustered, yet the three most distinct
docking poses, each orienting a different SOM (C10, C12, and
C14) to the heme iron, were chosen for further study. While
the binding of the substrate takes place with the enzyme in the
ferric resting state, the actual reaction is performed by CPDI.
Therefore, we investigated if CPDI affects the orientation of
caffeine. During the equilibration run all of them reoriented
such that C8 and C14 were pointing to the heme iron. In these
MD simulations, the COM of caffeine was at a distance of
around 9 Å from the heme iron and C8 and C14 were at 7−8
Å, which was again higher than in BLUES, where these average
distances were 8 and 5−6 Å, respectively, see Figure S5 and
Table S4. In contrast to the simulation with the ferric iron, the
standard MD CPDI simulations showed distances of the
SOMs to the heme iron smaller than 6 Å for less than 9% of
the frames (Table S5). Interestingly, we observe a stronger
preference for C8 than in the ferric heme simulations for both
standard MD and BLUES (see Table S6). However, these
SOMs are located closely to each other suggesting only a
minor difference between heme and CPDI poses. The larger
distances are probably caused by the oxygen atom bound to
the heme iron and a reduced net charge of the iron-center.
These larger distances from the heme iron are correlated with
shorter distances to the aromatic cluster (Figure S6).
Figure 5 summarizes the percentages of simulation frames in
which each SOM was closest to the heme iron for all
simulations. The simulations are ordered by the distance of the
COM of the ligand from the heme iron. In binding poses
where the COM is located more than 9 Å from the heme iron,
a clear shift toward C12(N3) and C10(N1) is observed. This
might suggest that for the binding poses, where the ligand is
located further from the heme iron, the metabolite distribution
changes and favors formation of PX and TB, while at closer
distances TP and TMU are expected as main metabolites.
Two Spin States−Two Mechanisms? The work of Regal
et al.12 suggests a more complicated picture of caffeine
dynamics onto which our simulations may shed light. At low
caffeine concentrations, PX is the main metabolite and the
protein is observed to be in a high spin state. They determined
an average distance for all aromatic nitrogens at roughly 7.3 Å,
suggesting a favored binding mode that is too far from the
heme iron to explain metabolism. Indeed, in many of the MD
simulations that start with the caffeine close to the heme, it is
seen to move further away, toward the aromatic cluster (Figure
4, Figure S6, Tables S1−3). In the MD and BLUES
simulations that place the caffeine at a larger distance, we
observe orientations of the substrate, which point C12 toward
the heme iron for appreciable amounts of time which is in
agreement with the experimentally observed product for-
mation. This binding mode does not only provide caffeine
favorable interactions with Phe226 via π−π stacking, see Figure
S6, but also places it in a more spacious cavity above the I-helix
giving it a higher conformational freedom to rotate.
At high caffeine concentrations, Regal et al.12 observe a shift
in the product formation and in the spin-state of the enzyme to
72% high spin and 28% low spin, see Table 2. We propose that
the 28% of low spin corresponds to a situation in which two
caffeine molecules bind to the active site forcing one molecule
closer to the heme. In Table 2, we compute the normalized
product formation for the 100% low spin state as the
distribution that would lead to the observed product formation
at 25 mM, taking into account the mixed spin state and
increased activity (approximately by a factor of 2.112) at the
higher concentration. For a 100% low spin state, a 69%
preference for product TP with C14 pointing toward the heme
and a 5-fold increase in activity relative to the 100% high spin
state would be necessary to lead to the observed product
formation.
In Figure 6, we summarize the renormalized metabolite
yields corresponding to different spin states in Table 2 and
compare them to the percentages of the closest SOM to the
heme iron throughout our simulations. The main SOM of
caffeine in CYP1A2 in its high spin state is N3, which is also
the SOM oriented toward the heme iron for more than 50% of
the time in both MD and BLUES simulations. In the low spin
state, which is present during 28% of time at high caffeine
Table 2. Observed Product Formation (Normalized) As
Described by Regal et al.12 at 5 and 25 mM Caffeinea
normalized product formation
SOM
5 mM
(100% HS)
25 mM
(72% HS + 28% LS)
100%
high spin
100%
low spin
N1-C10 (TB) 0.11 0.22 0.11 0.25
N3-C12 (TX) 0.78 0.17 0.78 0
N7-C14 (TP) 0.12 0.56 0.12 0.69
C8 (TMU) 0 0.05 0 0.07
aWe propose that the data at 25 mM with an increased overall
turnover by a factor 2.1 is the weighted average of an HS product
formation and an LS product formation at fivefold increased activity.
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concentrations, the main SOM is N7, corresponding to the
most preferred SOM in the simulations, where caffeine is in
close vicinity to the heme.
Summarizing, a single substrate molecule in the active site
prefers to bind close to the aromatic cluster and relatively far
away from the heme group. The orientations that are observed
for simulations at this distance agree with the experimentally
observed product formation at low concentrations. At higher
concentrations, a spin shift is experimentally observed,
resulting from a shorter substrate-heme distance. Simulta-
neously, a shift in the product formation is observed. The
orientation of the substrate in simulations at shorter distances
agrees with this altered product formation. We propose that a
second caffeine molecule in the active site could be the cause
for placing the first substrate molecule closer to the heme iron.
MD Simulation with Two Ligands in the Active Site.
In order to explore the possibility of simultaneous binding of
two ligands in the active site of CYP1A2, we simulated such a
complex with standard MD for 1 μs. The initial structure was
created from the initial binding poses of caffeine in cluster 1
and cluster 4 with the enzyme in the ferric state. Both
structures were overlaid and the caffeine molecule in the
binding mode from cluster 1 was added to the starting
structure of cluster 4. This approach was preferred over a new
ab initio docking of the two molecules, as, for example,
described for Aflatoxin B1 in Cytochrome P450 3A4,58 as the
two poses represented by clusters 1 and 4 were naturally
observed in MD simulations previously and seemed to be
readily accommodated in the structure. The system was
initially minimized in MOE,59 and subsequently the complex
was minimized, equilibrated, and simulated as described above
for the simulations of CYP1A2 with one ligand.
In the production run, both ligands were very stable; the
COM of the caffeine molecule closer to the heme iron
(Caffeine 1) was located 7 Å from the heme iron whereas the
COM of the second molecule (Caffeine 2) was located around
13−14 Å from the heme iron. These distances did not change
significantly during the simulation, see Figure S7. Caffeine 1 in
the beginning of the production run rotates which results in an
orientation that resembles simulations of clusters 0, 1, and 3,
that is, with C8 and C14(N7) pointing toward the heme iron.
Caffeine 1 stays in this orientation for more than 98% of
simulation time with the C8, C14(N7) within 5 Å from the
heme iron (Tables S2−3). Caffeine 2 is stabilized by aromatic
stacking with Phe226 and Phe260 from both sides and Phe256
from the top. It remains in the same orientation throughout
the simulation. The importance of aromatic interactions in
CYPs is demonstrated in the defense mechanism of Antarctic
sponges.60 Here, two small molecules inhibit CYP315a1 and
CYP314a1 by aromatic interactions within the active site.
Figure 7 shows a snapshot from this simultaneous binding of
two caffeine molecules into CYP1A2.
The stability of the protein conformation with two ligands
bound was monitored in order to investigate possible effects on
the protein upon binding of two caffeine molecules. Figure S8
shows the backbone root-mean-square-deviation (RMSD)
curves for this simulation and for the simulations of cluster 1
and cluster 4. Despite the steeper increase of the RMSD curve
of protein with two ligands bound, the overall value does not
exceed the RMSD from the simulations starting from Cluster 1
and 4. This suggests that simultaneous binding of two caffeine
Figure 6. (Left) Renormalized metabolite formation at different spin states, where the bars indicate which SOM has to be the closest to the heme
in order for the SOM’s metabolism to take place. (Right) Percentages of the corresponding orientation of caffeine during MD (full) and BLUES
(striped) simulations. The labels above bars show the percentages of corresponding orientation rounded to two decimal places.
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molecules does not have a negative impact on the CYP1A2
stability and in fact may be thermodynamically reasonable. A
similar simultaneous binding of two pyrene molecules to the
active site of CYP1A2 has been previously suggested by Sohl et
al.61,62
Under physiological conditions in humans, much lower
concentrations of caffeine (<100 μM) are usually present, and
paraxanthine remains the main metabolite, supporting the
proposed mechanism with one caffeine molecule in the active
site. On the other hand, a double occupancy of the active site
might be responsible for the caffeine-induced enhanced
metabolism of several druglike compounds.63 Cameron et
al.64 described heterotropic cooperativity of acetaminophen
and caffeine binding in CYP3A4, leading to enhanced
metabolism of caffeine. Multiple molecules binding to the
active site of CYP3A4 has been described for ketoconazole
experimentally65 and computationally66 and was postulated for
aflatoxin B158 based on observed homotropic cooperativity.67
■ CONCLUSION
In this work, we investigated the binding modes of caffeine to
its metabolizing enzyme CYP1A2 via standard molecular
dynamics and the enhanced ligand sampling method BLUES.
We observed a clear preference of orientation of the N7−C14
and C8 sites of metabolism toward the heme iron, when the
center of mass of the ligand was in the vicinity of the active
site. This is in agreement with previously published
experimental results showing an altered rate of metabolism
and shorter caffeine−iron distances at high caffeine concen-
trations. Preference of N7−C14 and C8 metabolism is also
expected from quantum mechanically derived activation
energies from literature, which were slightly lower than the
activation energies for other SOMs.
In case of caffeine bound further from the heme, we could
see a more pronounced conformational freedom due to a larger
cavity, where BLUES was able to sample binding poses with all
SOMs oriented toward the heme. Additionally, this was the
only case where we could observe the N3−C12 moiety facing
the heme iron for a significant amount of time. This binding
mode still requires the substrate to transiently approach the
heme before metabolism takes place. We suggest that the
further removed binding mode corresponds to the binding
mode of caffeine when it is present in lower concentrations,
where the main metabolite, paraxanthine, is formed. We
propose a mechanism, where at higher concentrations two
caffeine molecules are accommodated in the active site, forcing
one caffeine molecule to be in close vicinity (<6 Å) of the
heme iron, leading to formation of theophylline as the main
metabolite. To confirm our theory, we simulated simultaneous
binding of two caffeine molecules bound to CYP1A2, which
indeed lead to stable binding poses with N7−C14 and C8
SOM oriented toward the heme. Moreover, such binding did
not disrupt the overall stability of the protein and both caffeine
molecules were very stably interacting with the key active site
residues. Taken together, the work of Regal et al.,12
complemented by the simulations described in this work,
draw a complex but consistent picture of caffeine metabolism
by CYP1A2, which might shed more light on caffeine-drug
interactions in humans.
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